EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy

Angel Guan, Justin J-L Wong iD

Cancer Medicine · 2024-04 · 13 (7)

DOI: 10.1002/cam4.6989 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 28.03.2024. Verfasst von Angel Guan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Epigenetics and RNA Biology Laboratory, Charles Perkins Centre, University of Sydney, Camperdown, Australia. Hauptthemen laut MEDLINE: Adenosine, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 281 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New South Wales ministry of Health, National Health and Medical Research Council, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The N6‐methyladenosine (m6A) RNA modification has gained significant prominence as a new layer of regulatory mechanism that governs gene expression. Over the past decade, various m6A regulators responsible for introducing, eliminating, and recognising RNA methylation have been identified. Notably, these m6A regulators often exhibit altered expression patterns in cancer, occasionally offering prognostic value. Nonetheless, the complex roles of these regulators in human cancer pathology remain enigmatic, with conflicting outcomes reported in different studies.In recent years, a multitude of inhibitors and activators targeting m6A regulators have been reported. Several of these compounds have demonstrated promising efficacy in both in vitro and in vivo cancer models. These findings collectively underscore the dynamic landscape of m6A regulation in cancer biology, revealing its potential as a therapeutic target and prognostic indicator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineNeoplasmsHumansRNA MethylationRNA

Stichwörter der Autor:innen

N6‐methyladenosine (m6A)RNA modificationcancercancer therapychemoresistance

Substanzen

AdenosineRNA

Autor:innen und Institutionen

  • Epigenetics and RNA Biology Laboratory, Charles Perkins Centre, University of Sydney, Camperdown, Australia.
  • Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.

ORCID-Profile: Justin J-L Wong

Förderung

  • New South Wales ministry of Health
  • National Health and Medical Research Council
  • Australian Research Council
  • NSW Health

Zitieren

APA

Guan, A., & Wong, J. J. (2024). Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy. Cancer Medicine, 13(7). https://doi.org/10.1002/cam4.6989

Vancouver

Guan A, Wong JJ. Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy. Cancer Medicine. 2024;13(7). doi:10.1002/cam4.6989

BibTeX
@article{Guan2024,
  author = {Guan, Angel and Wong, Justin J-L},
  title = {Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {7},
  doi = {10.1002/cam4.6989}
}
Kostenlos starten →